TABLE 1.
Overall characteristics of the study population
| Variable | Subjects, n = 79 |
|---|---|
| Age (years) | 42 (35–46) |
| Male sex | 28 (35.4%) |
| BMI (kg/m2) | 27.5 ± 4.9 |
| BMI ≥ 30 kg/m2 | 21 (26.5%) |
| HCW's position | |
| Non‐medical (administrative workers) | 6 (7.5%) |
| Medical (nurse, physician) | 73 (92.5%) |
| Any morbidity | 39 (49.4%) |
| Obesity | 21 (26.5%) |
| Hypertension | 8 (10%) |
| Hypothyroidism | 4 (5%) |
| Heart disease | 0 (0%) |
| Asthma | 6 (7.5%) |
| Current or former smoker | 0 (0%) |
| Immunological disease | 0 (0%) |
| Previous SARS‐CoV‐2 exposure | 17 (21.5%) |
| Spike IgG titres (UA/ml)—first dose | 85 (60–153) |
| Side effects—first dose | 68 (86%) |
| Pain | 58 (73.5%) |
| Headache | 23 (29%) |
| Diarrhoea | 4 (5%) |
| Abdominal pain | 5 (6%) |
| Fever | 7 (9%) |
| Myalgias/arthralgias | 16 (20%) |
| Fatigue | 28 (35.5%) |
| Spike IgG titres (UA/ml)—second dose | 359 (284–1400) |
| Side effects—second dose | 64 (81%) |
| Pain | 58 (73.5%) |
| Headache | 24 (30.5%) |
| Diarrhoea | 3 (4%) |
| Abdominal pain | 4 (5%) |
| Fever | 8 (10%) |
| Myalgias/arthralgias | 20 (25.5%) |
| Fatigue | 33 (42%) |
Abbreviations: BMI, body mass index; HCW, healthcare worker; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; UA, arbitrary units.